Lastly, the finding of higher levels of MMP-7 and TIMP-3 in patients treated with VKA, as well as the reduced circulating levels of MMP-12, corroborates existing evidence showing impaired extracellular matrix (ECM) degradation in AF patients. This evidence concerns the gene TIMP3 and atrial fibrillation.